19 June 2013
Keywords: serono, saizen, available, adult, ghd, switzerland-based, biotechnology
Article | 17 January 2005
Switzerland-based biotechnology giant Serono's Saizen (somatropin for injection) is now available for the treatment of adult growth hormone deficiency following ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.